[Federal Register: August 19, 2005 (Volume 70, Number 160)]
[Notices]               
[Page 48780]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19au05-78]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 26, 2005, Sigma 
Aldrich Research, Biochemicals, Inc., 1-3 Strathmore Road, Natick, 
Massachusetts 01760, made application by letter to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of N-
Benzylpiperazine (7493), a basic class of controlled substance listed 
in Schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than October 18, 2005.

    Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-16465 Filed 8-18-05; 8:45 am]

BILLING CODE 4410-09-P